Cas:145-13-1 Pregnenolone manufacturer & supplier

We serve Chemical Name:Pregnenolone CAS:145-13-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Pregnenolone

Chemical Name:Pregnenolone
CAS.NO:145-13-1
Synonyms:EINECS 205-647-4;prenolon;ZK-5553;MFCD00003628;Pregn-5-en-20-one, 3-hydroxy-;prenenolone;Pregnelone;Pregnenlolone;3-Hydroxypregn-5-en-20-one;Pregnenolone;3β-Hydroxy-5-pregnen-20-one;5-Pregnen-3β-ol-20-one;pregnolon;Progeserone
Molecular Formula:C21H32O2
Molecular Weight:316.478
HS Code:2937290090

Physical and Chemical Properties:
Melting point:188-190 °C
Boiling point:443.3±45.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.550
PSA:37.30000
Exact Mass:316.240234
LogP:4.52

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like EINECS 205-647-4 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Progeserone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Progeserone Use and application,Pregn-5-en-20-one, 3-hydroxy- technical grade,usp/ep/jp grade.


Related News: This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. 1-thio-β-D-glucopyranose, 2,3,4,6-tetraacetate 1-(dimethylcarbamodithioate) manufacturers Prime Minister Naftali Bennett, launching the campaign, said President Isaac Herzog would be the first to receive the booster, on Friday. methyl 2-(3-chloro-4-((3-((3-methoxy-7-propylbenzo[d]isoxazol-6-yl)oxy)propyl)thio)phenyl)acetate suppliers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. [1-Methylamino-meth-(E)-ylidene]-thiophosphoramidic acid O,S-dimethyl ester vendor & factory.